Compare MAN & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAN | ATRC |
|---|---|---|
| Founded | 1948 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | 1994 | 2005 |
| Metric | MAN | ATRC |
|---|---|---|
| Price | $41.52 | $56.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | $52.33 | ★ $55.78 |
| AVG Volume (30 Days) | ★ 991.7K | 914.1K |
| Earning Date | 10-15-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.47% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | ★ 1.19 | 0.18 |
| Revenue | ★ $17,957,100,000.00 | $201,630,000.00 |
| Revenue This Year | $6.49 | $13.42 |
| Revenue Next Year | $3.49 | $12.12 |
| P/E Ratio | ★ $34.81 | $311.17 |
| Revenue Growth | 0.58 | ★ 15.40 |
| 52 Week Low | $25.15 | $25.36 |
| 52 Week High | $63.88 | $61.70 |
| Indicator | MAN | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 20.20 | 53.78 |
| Support Level | $29.25 | $26.95 |
| Resistance Level | $57.29 | $61.70 |
| Average True Range (ATR) | 2.52 | 2.35 |
| MACD | -1.23 | -0.26 |
| Stochastic Oscillator | 3.93 | 62.26 |
ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.